Skip to main content
. 2023 Sep 30;15(19):4237. doi: 10.3390/nu15194237

Table 2.

Clinical characteristics of the group showing serum uric acid levels ≥ 5 mg/dL in females with moderate to severe sleep-disordered breathing.

Serum Uric Acid < 5 mg/dL (n = 203) Serum Uric Acid ≥ 5 mg/dL (n = 160) p Value
Age, years old 66 ± 10 66 ± 9 0.45
Age ≥ 60 years old, n (%) 160 (79) 129 (81) 0.67
BMI, kg/m2 24.1 ± 3.9 26.1 ± 4.4 <0.0001
BMI ≥ 25 mg/m2, n (%) 69 (43) 91 (57) 0.0002
Menopausal status, post, n (%) 178 (88) 151 (94) 0.0299
Current smoking, n (%) 2 (2) 3 (2) 0.9477
Drinking habit ≥ 4 day/week, n (%) 19 (9) 18 (11) 0.5545
3% ODI, events/h 21.6 ± 7.3 21.6 ± 7.8 0.9520
CT90, % 3.4 ± 3.9 4.2 ± 7.4 0.1308
Creatinine clearance, mL/min 86.2 ± 31.1 82.5 ± 29.0 0.2505
Creatinine clearance < 70 mL/min, n (%) 61 (30) 54 (34) 0.4518
Hypertension, n (%) 123 (61) 100 (64) 0.5342
Diabetes mellitus, n (%) 24 (12) 36 (23) 0.0067
Dyslipidemia, n (%) 118 (68) 94 (68) 0.9550

Data are presented as the mean ± SD or numbers. Moderate to severe sleep-disordered breathing was defined as Acti-ODI3% ≥ 15. BMI, body mass index; ODI, oxygen desaturation index; CT, cumulative percentage time at saturation of percutaneous oxygen below 90%.